Lupin launches Meloxicam Capsules

28 Dec 2020 Evaluate

Lupin has launched Meloxicam Capsules, 5 mg, and 10 mg, having received an approval from the United States Food and Drug Administration (USFDA). Meloxicam Capsules, 5 mg and 10 mg, is the generic equivalent of Vivlodex Capsules, 5 mg and 10 mg, of Zyla Life Sciences US, Inc., and indicated for management of osteoarthritis (OA) pain.

Meloxicam Capsules (RLD: Vivlodex) had an annual sales of approximately $11 million in the U.S. (IQVIA MAT October 2020).

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2124.65 -26.40 (-1.23%)
01-Feb-2026 14:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.80
Dr. Reddys Lab 1199.65
Cipla 1325.70
Zydus Lifesciences 887.35
Lupin 2124.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×